Analysis argues Theranos-style fraud has become normalized
A commentary discusses how deceptive practices and inflated startup claims reminiscent of Theranos have increasingly become standard industry practice.
A commentary discusses how deceptive practices and inflated startup claims reminiscent of Theranos have increasingly become standard industry practice.